WEBINAR: Busting psychedelic myths and exploring cross cultural taboos and nuances
Wednesday October 28 @ 11:00 am - 12:30 pm
Don’t miss out – Get your tickets early!
Join this free, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.
In this webinar special guest speakers, Kyle Buller and Joe Moore from Psychedelics Today will share their experiences of breaking down the stigma and myths associated with psychedelic and cross-cultural psychedelic taboos and nuances. Dr. Alana Roy will share the current challenges and triumphs working in the field of psychedelic science in Australia and how you can help break down these barriers to ensure Australia has access to psychedelic medicine.
After this screening, a live “bust a myth/you can’t ask that” mental health panel Q and A discussion will occur with Dr. Alana Roy and Renee Harvey. Participants will have the opportunity to challenge assumptions, biases, and culturally constructed beliefs. Furthermore, participants will be given practical tools on how to become educated, ethical, and informed psychedelic advocates to help join the movement in Australia.
Topic: Busting psychedelic myths and exploring cross-cultural taboos and nuances
Date: Wednesday 28 October 2020
Time: 10:55am for 11:00am start – 12:30pm (incl Q&A) (AEST)
The presentation WILL BEGIN AT 11:00am.
Location: Online. A link will be emailed to you with the viewing details.
More about medicinal psychedelic treatments:
Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.
The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.
More about the presenters
Co-Founder, Psychedelics Today
Kyle earned his B.A. in Transpersonal Psychology from Burlington College, where he focused on studying the healing potential of non-ordinary states of consciousness by exploring shamanism, Reiki, local medicinal plants and plant medicine, Holotropic and Dreamshadow Transpersonal Breathwork.
Kyle also earned his M.S. in Clinical Mental Health Counseling with an emphasis on Somatic Psychology. Kyle’s clinical background in mental health consists of working with at-risk teenagers in crisis and with individuals experiencing an early-episode of psychosis and providing counseling to undergraduate/graduate students in a university setting.
Co-Founder, Psychedelics Today
Joe is a co-founder of Psychedelics Today. He is a long time student of psychedelics, psychology, and of the pioneering psychedelic psychiatrist, Dr. Stanislav Grof. After discovering the work of Dr. Stanislav Grof in 2001, Joe began studying psychedelics. In 2003 he started participating heavily in Holotropic Breathwork workshops. Joe spent time community organizing in Boston around permaculture, psychedelics, breathwork, shamanism and more. His biggest event in Boston was the “Ayahuasca Monologues” in 2011.
Ph. D Psychology, B. A Social Work (MHSW)
Dr Alana Roy is a psychologist, social worker and therapist with a background in mental health, suicide prevention, trauma and abuse. Alana works at several universities as a Research Fellow and supervisor of students on placement. She is dedicated to psychedelic assisted psychotherapy and plant medicines. She has engaged with, and provides integration therapeutic support services for communities across Australia. Alana passionately advocates for public policy, community education and legislative changes so that these treatments are regulated and supported by a skilled sector.
Manager of the Psychedelic Therapy Development Program, Mind Medicine Australia
Renee has had a long career in the UK as a Consultant Clinical Psychologist in the NHS and more recently as an Honorary Research Fellow at Imperial College London in the study of psilocybin for treatment resistant depression. She has been responsible for leading in service development for people with complex emotional needs across Sussex (UK), establishing three specialist services, including staff appointments, training and supervision, and in clinical delivery in these services. She established various training courses and treatment programmes during this time, and regularly delivered lectures and courses at various levels. Renee specialised in training clinicians in skills for working with individuals with complex needs across the UK as well as internationally, including Europe, and Japan. Renee was also a key member of developing psychedelic interest groups in Brighton, and in establishing and running a psychedelic Integration Circle in Brighton UK.
Tania de Jong AM
LL.B (Hons), GradDipMus
Founder & Deputy Chair of Mind Medicine Australia
Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 3 charities over the past 3 decades. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global. She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018.
Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.